Medical - global

A group of drug companies competing with one another to be among the first to develop coronavirus vaccines are planning to pledge early next week that they will not release any vaccines that do not follow rigorous efficacy and safety standards, according to representatives of three of the companies.

Country / Region Tags:

Europe

Global

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pharma Companies Plan Joint Pledge on Vaccine Safety
Log in or register to post comments

Delivering super-cooled COVID-19 vaccine a daunting challenge for some countries

Fri, 2020-09-04 17:28 — mike kraft

Delivering super-cooled COVID-19 vaccine a daunting challenge for some countries Getting a coronavirus vaccine from manufacturing sites to parts of the developing world supply will be an immense challenge, given the need to store some vials at temperatures as low as minus 80 Celsius (-112 Fahrenheit), Deutsche Post warned on Tuesday. Matthias Inverardi U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Read more about Delivering super-cooled COVID-19 vaccine a daunting challenge for some countries
Log in or register to post comments

Roche to offer SARS-CoV-2 rapid antigen test to CE Mark accepting countries, apply for EUA

Fri, 2020-09-04 17:21 — mike kraft

Roche to offer SARS-CoV-2 rapid antigen test to CE Mark accepting countries, apply for EUA - Homeland Preparedness News Roche announced this week plans to launch a SARS-CoV-2 Rapid Antigen Test capable of 15-minute turnarounds for markets accepting the CE Mark and file for Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). Meant for use … Read More » Chris Galford Homeland Preparedness News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Roche to offer SARS-CoV-2 rapid antigen test to CE Mark accepting countries, apply for EUA
Log in or register to post comments

Results of Russia's COVID-19 vaccine produced antibody response: The Lancet

Fri, 2020-09-04 09:59 — mike kraft

Results of Russia's COVID-19 vaccine produced antibody response: The Lancet Russia's "Sputnik-V" COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics. Polina Ivanova U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Results of Russia's COVID-19 vaccine produced antibody response: The Lancet
Log in or register to post comments

Widespread COVID-19 vaccinations not expected until mid-2021, WHO says

Fri, 2020-09-04 09:40 — mike kraft

Widespread COVID-19 vaccinations not expected until mid-2021, WHO says The World Health Organization does not expect widespread vaccinations against COVID-19 until the middle of next year, a spokeswoman said on Friday, stressing the importance of rigorous checks on their effectiveness and safety. Stephanie Nebehay U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Widespread COVID-19 vaccinations not expected until mid-2021, WHO says
Log in or register to post comments

Symptoms can last much longer than expected--CDC study

Wed, 2020-09-02 12:26 — mike kraft

Coronavirus Disease 2019 (COVID-19) CDC provides credible COVID-19 health information to the U.S. CDC Centers for Disease Control and Prevention

(CNN) The US Centers for Disease Control and Prevention has said most people who tested positive for Covid-19 can return to work or school 10 days after the onset of symptoms, unless the illness requires hospitalization.

Country / Region Tags:

General Topic Tags: